Gowdhami Mohan
Sleep Medicine · Clarksdale, MSNPI 1114921806
Payments from drug & device makers
What this record shows
Almost everything reported here is food and beverage — 96.5% of the total across 284 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. It is spread thinly across 29 manufacturers, the largest accounting for just 16.2% — the pattern of someone who eats at a lot of different presentations. Reporting peaked in 2021 at $1,345 and has fallen 96.3% since, to $50 in 2024.
Across 284 payments — averaging $16.75 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Boehringer Ingelheim$772
- AstraZeneca$584
- GSK$435
- Grifols USA, LLC$358
- Insmed, Inc.$305
- Takeda Pharmaceuticals U.S.A., Inc.$272
- plus $2K from 23 others
Across 350 payments — averaging $11,895 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.
- Modernatx, Inc.$3.5M
- Mylan Specialty L.p.$213K
- GSK$203K
- Sanofi Pasteur Inc.$146K
- Novo Nordisk AS$30K
- Chugai Pharmaceutical Co., Ltd.$15K
- plus $31K from 3 others
What the payments were for
- Food & beverage$4,59297%
- Education$1663%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Boehringer Ingelheim | 48 | $772 |
| AstraZeneca | 32 | $584 |
| GSK | 27 | $435 |
| Grifols USA, LLC | 23 | $358 |
| Insmed, Inc. | 15 | $305 |
| Takeda Pharmaceuticals U.S.A., Inc. | 14 | $272 |
| Electromed, Inc. | 25 | $250 |
| Jazz Pharmaceuticals Inc. | 14 | $236 |
| Harmony Biosciences LLC | 14 | $173 |
| Mylan Specialty L.p. | 8 | $161 |
| Philips North America LLC | 5 | $140 |
| Genentech USA, Inc. | 8 | $131 |
| Paratek Pharmaceuticals, Inc. | 6 | $127 |
| Actelion Pharmaceuticals US, Inc. | 7 | $115 |
| Regeneron Healthcare Solutions, Inc. | 6 | $110 |
| Resmed Corp | 5 | $92 |
| Mallinckrodt Hospital Products Inc. | 5 | $77 |
| Sanofi | 4 | $59 |
| Shire North American Group Inc | 3 | $53 |
| CSL Behring | 2 | $52 |
| Novo Nordisk | 1 | $50 |
| Circassia Inc. | 3 | $47 |
| Merck | 2 | $36 |
| Teva Pharmaceuticals USA, Inc. | 2 | $30 |
| United Therapeutics Corporation | 1 | $22 |
| Fisher & Paykel Healthcare Inc | 1 | $22 |
| Mallinckrodt Enterprises LLC | 1 | $19 |
| Amgen | 1 | $17 |
| Advanced Respiratory, Inc | 1 | $14 |
How this compares
Too few sleep medicine providers in Mississippito place this figure against a meaningful peer group, so we don't.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Albuterol Sulfate HfaAlbuterol Sulfate | 14 | $359 |
Paid to pharmacies, not to this prescriber.
Other sleep medicine in Clarksdale
- Brenda HinesFlowood$56K
- Andrea LewisJackson$36K
- Christopher KarcherOcean Springs$26K
- John DouglasGulfport$8K
- Sanjay RatnakantSouthaven$2K
- John BoswellColumbus$2K
- Kary WhiteheadMeridian$2K
- Mohammad UllahJackson$2K
- Alexandra EdwardsLaurel$1K
- Dani ChoufaniJackson$1K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.